Search Within

Kaitlyn Ruth Shank

Formats
  1. Journal Article (10)
  2. Meeting Abstract (9)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (20)
  2. Center for Hematologic Malignancies (20)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (20)
  4. Department of Medicine (20)
  5. Executive Committee, Center for Hematologic Malignancies (20)
  6. GSK Faculty (20)

More Groups

People
  1. Ross Levine (20)
  2. Alan Shih (9)
  3. Franck Rapaport (9)
  4. Matthew Keller (9)
  5. Barbara Spitzer (7)
  6. Efthymia Papalexi (5)

More People

Years
  1. 2020 (1)
  2. 2018 (2)
  3. 2017 (2)
  4. 2016 (3)
  5. 2015 (6)
  6. 2014 (4)

More Years

Publications
  1. Blood (10)
  2. Cancer Cell (3)
  3. Haematologica (2)
  4. Cancer Discovery (1)
  5. Journal of Clinical Investigation (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Cell Press (3)
  3. Ferrata Storti Foundation (2)
  4. Nature Publishing Group (2)
  5. American Association for Cancer Research (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis
    Journal Article

    Viny, A. D.; Ott, C. J.; Spitzer, B.; Rivas, M.; Meydan, C.; Papalexi, E.; Yelin, D.; Shank, K.; Reyes, J.; Chiu, A.; more...
    Journal of Experimental Medicine (2015)

    Fulltext@MSK | Save
  • DNMT3A R882 mutation promote chemoresistance and therapeutic relapse through impaired DNA-damage sensing
    Meeting Abstract

    Guryanova, O.; Shank, K.; Garrett-Bakelman, F.; Spitzer, B.; Ganzel, C.; Rapaport, F.; Keller, M.; Evangelista, L.; Glass, J.; Rowe, J.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
    Journal Article

    Meyer, S.; Keller, M.; Chiu, S.; Koppikar, P.; Guryanova, O.; Rapaport, F.; Xu, K.; Manova, K.; Pankov, D.; O'reilly, R.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia
    Journal Article

    Shih, A. H.; Jiang, Y.; Meydan, C.; Shank, K.; Pandey, S.; Barreyro, L.; Antony-Debre, I.; Viale, A.; Socci, N.; Sun, Y.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • AG-221, a small molecule mutant IDH2 inhibitor, remodels the epigenetic state of IDH2-mutant cells and induces alterations in self-renewal/differentiation in IDH2-mutant AML model in vivo
    Meeting Abstract

    Shih, A. H.; Shank, K. R.; Meydan, C.; Intlekofer, A. M.; Ward, P.; Thompson, C. B.; Melnick, A. M.; Travins, J.; Straley, K.; Gliser, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Mathematical optimization of JAK inhibitor dose and scheduling for MPN patients
    Meeting Abstract

    Shank, K. R.; Koppikar, P.; Bhagwat, N.; Keller, M. D.; Michor, F.; Levine, R. L.; Roditi, L. D.
    Blood (2014)

    Fulltext@MSK | Save
  • Conditional loss of Dnmt3a results in myeloproliferation and liver-specific myeloid expansion
    Meeting Abstract

    Guryanova, O. A.; Lieu, Y.; Shank, K. R.; Rivera, S.; Garrett-Bakelman, F. E.; Glass, J.; Keller, M. D.; Pandey, S.; Tovbin, D.; Weinstein, A. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms
    Journal Article

    Bhagwat, N.; Koppikar, P.; Keller, M.; Marubayashi, S.; Shank, K.; Rampal, R.; Qi, J.; Kleppe, M.; Patel, H. J.; Shah, S. K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Epigenetic profiling of leukemia stem cells in a model of TET2/FLT3-mutant AML
    Meeting Abstract

    Shih, A. H.; Jiang, Y.; Shank, K.; Pandey, S.; Viale, A.; Sun, Y.; Socci, N.; Robertson, A.; de Stanchina, E.; Hricik, T.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Improved efficacy of combination of JAK2 and Hedgehog inhibitors in myelofibrosis
    Meeting Abstract

    Bhagwat, N.; Keller, M. D.; Rampal, R. K.; Shank, K.; de Stanchina, E.; Rose, K.; Amakye, D.; Levine, R. L.
    Blood (2013)

    Fulltext@MSK | Save